Revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Champions Oncology, Inc. (CSBR)
Price$5.22Cached quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.4M | $56.9M | $50.2M | $53.9M | $49.1M | $41.0M | $32.1M | $27.1M | $20.2M | $15.4M | $11.2M | $8.9M | $11.6M | $8.3M | $7.1M | $6.9M |
| Gross profit | $28.5M | $28.6M | $20.8M | $24.3M | $25.5M | $19.6M | $15.1M | — | — | — | — | — | — | — | — | — |
| Gross margin | 48.00% | 50.15% | 41.38% | 45.18% | 51.88% | 47.74% | 47.08% | — | — | — | — | — | — | — | — | — |
| Research & development | $9.1M | $6.8M | $9.5M | $11.5M | $9.4M | $7.2M | $5.9M | $4.8M | $4.4M | $4.3M | $4.2M | $4.8M | $2.3M | $1.9M | $2.9M | $2.9M |
| Operating expenses | $60.6M | $52.4M | $57.5M | $59.1M | $48.5M | $40.7M | $33.9M | $26.8M | $21.6M | $22.2M | $21.5M | $22.1M | $17.8M | $14.5M | $16.2M | $12.1M |
| Operating income | −$1.1M | $4.6M | −$7.4M | −$5.3M | $607,000 | $366,000 | −$1.9M | $270,000 | −$1.4M | −$6.8M | −$10.3M | −$13.2M | −$6.3M | −$6.2M | −$9.1M | −$5.2M |
| Operating margin | −1.92% | 8.00% | −14.67% | −9.76% | 1.24% | 0.89% | −5.98% | 1.00% | −6.69% | −44.18% | −92.26% | −149.36% | −54.20% | −74.74% | −126.80% | −76.07% |
| EBITDA | $260,000 | $6.2M | −$5.5M | −$3.2M | $2.1M | $1.3M | −$1.1M | $876,000 | −$994,000 | −$6.6M | −$10.2M | −$13.0M | −$6.0M | −$6.0M | −$9.0M | −$5.2M |
| EBITDA margin | 0.44% | 10.81% | −10.88% | −5.86% | 4.29% | 3.15% | −3.41% | 3.24% | −4.91% | −43.09% | −90.86% | −146.95% | −52.35% | −72.31% | −125.33% | −75.46% |
| Net income | −$1.2M | $4.7M | −$7.3M | −$5.3M | $548,000 | $362,000 | −$2.1M | $128,000 | −$1.5M | −$6.9M | −$10.4M | −$13.1M | −$7.4M | −$6.3M | −$8.7M | −$3.8M |
| Net profit margin | −1.98% | 8.26% | −14.51% | −9.90% | 1.12% | 0.88% | −6.52% | 0.47% | −7.29% | −44.67% | −93.41% | −148.25% | −64.12% | −76.05% | −121.15% | −55.25% |
| Basic EPSper basic share | -$0.08 | $0.34 | -$0.54 | -$0.39 | $0.04 | $0.03 | -$0.18 | $0.01 | -$0.13 | -$0.64 | -$1.20 | -$2.20 | -$1.32 | -$1.44 | -$2.28 | -$1.32 |
| Diluted EPSper diluted share | -$0.08 | $0.33 | -$0.54 | -$0.39 | $0.04 | $0.02 | -$0.18 | $0.01 | -$0.13 | -$0.64 | -$1.20 | -$2.20 | -$1.32 | -$1.44 | -$2.28 | -$1.32 |
Owners
Reported shareholders
≈17.44%of listed shares
BATTERY MANAGEMENT CORP.2.42M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BATTERY MANAGEMENT CORP. | ≈17.44%2.42M shares |
NEA Management Company, LLC | ≈12.34%1.71M shares |
ACKERMAN JOEL | ≈7.61%1.06M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈2.17%301.35K shares |
TOCQUEVILLE ASSET MANAGEMENT L.P. | ≈2.13%295.66K shares |
MORGAN STANLEY | ≈1.70%235.4K shares |
BANK OF AMERICA CORP /DE/ | ≈1.54%214.06K shares |
RENAISSANCE TECHNOLOGIES LLC | ≈1.00%139.04K shares |
BlackRock, Inc. | ≈0.94%129.85K shares |
Mink Brook Asset Management LLC | ≈0.80%111.34K shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈0.55%76.3K shares |
HighTower Advisors, LLC | ≈0.30%41.9K shares |
VANGUARD FIDUCIARY TRUST CO | ≈0.24%33.24K shares |
NORTHERN TRUST CORP | ≈0.20%27.91K shares |
STATE STREET CORP | ≈0.19%26.2K shares |
Cambridge Investment Research Advisors, Inc. | ≈0.18%24.5K shares |
Bank of New York Mellon Corp | ≈0.16%21.61K shares |
ACADIAN ASSET MANAGEMENT LLC | ≈0.15%20.52K shares |
CITADEL ADVISORS LLC | ≈0.13%18.3K shares |
ESSEX INVESTMENT MANAGEMENT CO LLC | ≈0.13%18.22K shares |
Percentages use 13.89M shares of this listed class outstanding on Apr 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data